Dentate nuclei T2 relaxometry is a reliable neuroimaging marker in Friedreich's ataxia

European Journal of Neurology

Volumn 21, Issue 8, 2014, Pages 1131-1136

  Bonilha da Silva, C ^a   Bergo, F P G ^a   D'Abreu, A ^a   Cendes, F ^a   Lopes Cendes, I ^a   Franca M C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Dentate nuclei; Friedreich's ataxia; MRI; T2 relaxometry

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CAUDATE NUCLEUS; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DENTATE NUCLEUS; DISEASE SEVERITY; FEMALE; FRIEDREICH ATAXIA; FRIEDREICH ATAXIA RATING SCALE; HUMAN; MAGNETIC FIELD; MALE; MEASUREMENT ACCURACY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUTAMEN; RADIOLOGICAL PARAMETERS; RELAXATION TIME; SUBSTANTIA NIGRA; T2 RELAXOMETRY; WHITE MATTER; CEREBELLUM NUCLEUS; CROSS-SECTIONAL STUDY; DISEASE COURSE; FOLLOW UP; GENETICS; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CEREBELLAR NUCLEI; CHILD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FRIEDREICH ATAXIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; YOUNG ADULT;

EID: 84903878388     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12448     Document Type: Article

References (23)

1. Pandolfo M. Friedreich ataxia. Arch Neurol 2008; 65: 1296-1303.
2. Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol 2007; 6: 245-257.
3. Campuzano V, Montermini L, Moltò MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423-1427.
4. Koeppen AH. Friedreich's ataxia: pathology, pathogenesis and molecular genetics. J Neurol Sci 2011; 303: 1-12.
5. Koeppen AH, Michael SC, Knutson MD, et al. The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins. Acta Neuropathol 2007; 114: 163-173.
6. Schenck JF. Magnetic resonance imaging of brain iron. J Neurol Sci 2003; 207: 99-102.
7. Waldvogel D, Gelderen P, Hallet M. Increased iron in the dentate nucleus of patients with Friedreich's ataxia. Ann Neurol 1999; 46: 123-125.
8. Martin WR. Quantitative estimation of regional brain iron with magnetic resonance imaging. Parkinsonism Relat Disord 2009; 15(suppl3): S215-S218.
9. Hasan KM, Walimuni IS, Kramer LA, Narayana PA. Human brain mapping using atlas-based T2 relaxometry. Magn Reson Med 2011; 67: 731-739.
10. Hikita T, Abe K, Sakoda S, Tanaka H, Murase K, Fujita N. Determination of transverse relaxation rate for estimating iron deposits in central nervous system. Neurosci Res 2005; 51: 67-71.
11. Filla A, De Michele G, Cavalcanti F, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 1996; 59: 554-560.
12. Subramony SH, May W, Lynch D, et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology 2005; 64: 1261-1262.
13. Wansapura JP, Holland SK, Dunn RS, Ball WS. NMR relaxation time in the human brain at 3.0 tesla. J Magn Reson Imaging 1999; 9: 531-538.
14. Guimarães RP, D'Abreu A, Yasuda CL, et al. A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3. Mov Disord 2013; 28: 1125-1132.
15. Reetz K, Costa AS, Mirzazade S, et al. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain 2013; 136: 905-917.
16. Risacher SL, Shen L, West JD, et al. Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging 2010; 31: 1401-1418.
17. Akhlaghi H, Corben L, Georgiou-Karistianis N, et al. Superior cerebellar peduncle atrophy in Friedreich's ataxia correlates with disease symptoms. Cerebellum 2011; 10: 81-87.
18. Chevis CF, da Silva CB, D'Abreu A, et al. Spinal cord atrophy correlates with disability in Friedreich's ataxia. Cerebellum 2013; 12: 43-47.
19. Boddaert N, Sang KHLQ, Rötig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 2007; 110: 401-408.
20. Velasco-Sánchez D, Aracil A, Montero R, et al. Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia. Cerebellum 2011; 10: 1-8.
21. Fahey MC, Corben L, Collins V, Churchyard AJ, Delatycki MB. How is disease progress in Friedreich's ataxia best measured? A study of four rating scales. J Neurol Neurosurg Psychiatry 2007; 78: 411-413.
22. Brooks DJ, Luthert P, Gadian D, et al. Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels. J Neurol Neurosurg Psychiatry 1989; 52: 108-111.
23. Vymazal J, Brooks RA, Zak O, McRill C, Shen C, Di Chiro G. T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med 1992; 27: 368-374.